Circulating tumor DNA as prognostic markers of non-small cell lung cancer (NSCLC): a systematic review and meta-analysis
CtDNA positivity serves as a robust prognostic marker of worse survival and higher recurrence in NSCLC patients throughout the treatment cycle. Early ctDNA detection may facilitate timely therapeutic interventions and improve patient outcomes.
Authors
- BaoShan Cao
- Hongmei Zeng (ORCID: https://orcid.org/0000-0001-7315-245X)
- Xiaowei Chen (ORCID: https://orcid.org/0000-0001-6466-6248)
- Feng Sun (ORCID: https://orcid.org/0000-0002-5255-7543)
- Nana Guo
- Wanqing Chen
- Q X Zhou
- Meng Zhang
Institutions
- Shihezi University (CN)
- Xinjiang Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Tianjin Centers for Disease Control and Prevention (CN)
- Peking University Third Hospital (CN)
- Hebei Provincial Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- Translational Lung Cancer Research
- Published
- 2025-12-01
- DOI
- https://doi.org/10.21037/tlcr-2025-900
- Citations
- 1
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.94